The Level of Ets-1 Protein Is Regulated by Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Cancer Cells to Prevent DNA Damage

PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma

(2012) J. C. Brenner et al.   CANCER RESEARCH

Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

(2012) S. Ying et al.   CANCER RESEARCH

Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination

(2012) Z. Wang et al.   GENES & DEVELOPMENT

On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1

(2012) X. Luo et al.   GENES & DEVELOPMENT

Drug candidates derailed in case of mistaken identity

(2012) Heidi Ledford   NATURE

Systematic identification of genomic markers of drug sensitivity in cancer cells

(2012) Mathew J. Garnett et al.   NATURE

Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors

(2012) Elisabet Wahlberg et al.   NATURE BIOTECHNOLOGY

Poly(ADP-ribose) polymerase-1 protects from oxidative stress induced endothelial dysfunction

(2011) Cathérine Gebhard et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

(2011) Timothy A. Yap et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer

(2011) J. Chad Brenner et al.   CANCER CELL

The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest

(2011) Dana L. Madison et al.   DNA REPAIR

ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence

(2011) U Weyemi et al.   ONCOGENE

Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage

(2011) H. C. Kang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Drug resistant breast cancer cells overexpress ETS1 gene

(2010) Meltem Demirel Kars et al.   BIOMEDICINE & PHARMACOTHERAPY

DNA-dependent protein kinase is a novel interaction partner for Ets-1 isoforms

(2009) Souhaila Choul-li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ets-1 p51 and p42 isoforms differentially modulate Stromelysin-1 promoter according to induced DNA bend orientation

(2009) G. Leprivier et al.   NUCLEIC ACIDS RESEARCH

Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51

(2009) C Laitem et al.   ONCOGENE

Functional genomic screens identify CINP as a genome maintenance protein

(2009) C. A. Lovejoy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter

(2008) David Baillat et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Angiotensin II promotes poly(ADP-ribosyl)ation of c-Jun/c-Fos in cardiac fibroblasts

(2008) Dan Huang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

(2008) Vera Rocha-Perugini et al.   PLoS One

Efficient system for biotinylated recombinant Ets-1 production in Escherichia coli: A useful tool for studying interactions between Ets-1 and its partners

(2008) Clélia Laitem et al.   PROTEIN EXPRESSION AND PURIFICATION